about
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.HIV1 and the gut in the era of highly active antiretroviral therapy.Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature.Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.Ceftaroline for complicated skin and skin-structure infections.Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis model.Telavancin's interactions with the bacterial cell membrane.Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections.Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel.Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis.Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin.Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies.Importance of gls24 in virulence and stress response of Enterococcus faecalis and use of the Gls24 protein as a possible immunotherapy target.Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas.The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia.HIV-treating physicians in Houston express their professional opinions on the public health implications of antiretroviral therapyJejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitutionInterleukin-2 in clinical trials: other factors to be consideredVancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapyOccult Staphylococcus aureus bacteremia: other points to considerDrug-resistant genotyping in HIV-1 therapyA new lipoglycopeptide: telavancin
P50
Q34822824-2CE6613F-6D47-403C-8CB9-BA857BD58F63Q34848194-1D1BB5DE-1B21-4741-9A7B-B71ACDF60D63Q35125705-69ACA625-AA4E-48E6-8971-237DDF82AB7AQ37286901-F6C63828-1E29-4DBE-B372-F7C0B12C0D98Q37733561-73BD3983-D29B-4453-AEDF-769CA0920D2BQ37769646-BF6E8174-759C-4ABF-97E9-FD0F6975A5F4Q38048845-2BA6E8C3-E8E2-4BE3-9C07-242B91D052F2Q38797012-3270F894-F56C-4705-B405-17256B01A8B6Q39392092-348B404E-E7CB-4E33-BA53-0C100A6BFB72Q39894154-553385D9-9474-4EDA-A37B-931949DA5D55Q40336487-753F60F1-E327-40BF-956A-AAA694FE31F3Q40548386-74976E09-4382-4606-BAE8-F8E289EE7F30Q40799022-D0FFCA32-FC62-4AE6-B558-28F4E67BDD70Q41024091-0505F2A0-5935-4991-9D17-264D004D96D1Q41780217-EA9FE09A-F441-45E3-8A65-FF34D0C0D9E6Q41961174-5E2508EF-E408-44E6-86CC-3AEEC5864782Q42110143-718591F7-52E9-4FBA-92A3-F96A8F29AB02Q44051423-6715D9BD-A9DB-4703-BE27-9F7CFE5050CAQ47322172-D15798B0-9867-4ADB-AEA6-CE8816FBE91DQ52562028-AA5FFF3E-EE33-423E-ACAB-7FA19D6CB4BEQ53977732-9C3D2ABB-CD4F-4439-9628-FC75F69699C4Q55423934-62CF56BA-2BCD-4322-B4CC-3E76C3A7D783Q56945584-02065C2A-FB5A-4580-AAD7-D9A6264EF799Q58646606-1D61C1F5-11AC-4A4E-A527-1B6DFEF72406Q73424362-6271537D-E314-4CF3-8D0F-26BD52480FFFQ83022695-EC4B42F9-C344-4070-8561-AE6C9D3B5ABEQ86148070-17BF3E2B-B78F-4C38-B31B-56AE94C480A4Q93926804-F8D5E5CE-3CB0-4E1D-B00E-2DAE64F97FA3Q94705356-6D656B98-4526-49F8-BC65-F34C4D8E7DE5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esteban C Nannini
@ast
Esteban C Nannini
@en
Esteban C Nannini
@es
Esteban C Nannini
@nl
Esteban C Nannini
@sl
type
label
Esteban C Nannini
@ast
Esteban C Nannini
@en
Esteban C Nannini
@es
Esteban C Nannini
@nl
Esteban C Nannini
@sl
prefLabel
Esteban C Nannini
@ast
Esteban C Nannini
@en
Esteban C Nannini
@es
Esteban C Nannini
@nl
Esteban C Nannini
@sl
P106
P21
P31
P496
0000-0002-8472-7965